Alcohol Use Disorders
303.90 Alcohol dependence
305.00 Alcohol abuse
AMPHETAMINE (OR AMPHETAMINE-LIKE) USE DISORDERS
304.40 Amphetamine dependence
305.70 Amphetamine abuse
CANNABIS USE DISORDERS
304.30 Cannabis dependence
305.20 Cannabis abuse
COCAINE USE DISORDERS
304.20 Cocaine dependence
305.60 Cocaine abuse
HALLUCINOGEN USE DISORDERS
304.60 Hallucinogen dependence
305.30 Hallucinogen abuse
INHALANT USE DISORDERS
304.60 Inhalant dependence
305.90 Inhalant abuse
NICOTINE USE DISORDERS
305.10 Nicotine dependence
OPIOID USE DISORDERS
304.00 Opioid dependence
305.50 Opioid abuse
PHENCYCLIDINE USE DISORDERS
304.90 Phencyclidine dependence
305.90 Phencyclidine abuse
SEDATIVE, HYPNOTIC, OR ANXIOLYTIC SUBSTANCE USE DISORDERS
304.10 Sedative, hypnotic, or anxiolytic dependence
305.40 Sedative, hypnotic, or anxiolytic abuse
POLYSUBSTANCE USE DISORDER
304.80 Polysubstance dependence
(For other listings, consult DSM-IV manual.)
Many drugs and volatile substances are subject to abuse (as noted in previous plans of care). This disorder is a continuum of phases incorporating a cluster of cognitive, behavioral, and physiological symptoms that include loss of control over use of the substance and a continued use of the substance despite adverse consequences. A number of factors have been implicated in the predisposition to abuse a substance (e.g., biological, biochemical, psychological [including developmental], personality, sociocultural and conditioning, and cultural and ethnic influences). However, no single theory adequately explains the etiology of this problem.
This plan of care addresses issues of dependence and is to be used in conjunction with plans of care relative to acute intoxification/withdrawal from specific substance(s).
CLIENT ASSESSMENT DATA BASE
Refer to appropriate acute plan of care regarding involved substance(s).
Drug (including-alcohol) Screen: Identifies drug(s) being used.
Addiction Severity Index (ASI) Assessment Tool: Produces a “problem severity profile” of the patient, including chemical, medical, psychological, legal, family/social and employment/support aspects, indicating areas of treatment needs.
Other Screening Studies (e.g., Hepatitis, HIV, TB): Depend on general condition, individual risk factors, and care setting.
1. Provide support for decision to stop substance use.
2. Strengthen individual coping skills.
3. Facilitate learning of new ways to reduce anxiety.
4. Promote family involvement in rehabilitation program.
5. Facilitate family growth/development.
6. Provide information about condition, prognosis, and treatment needs.
1. Responsibility for own life and behavior assumed.
2. Plan to maintain substance-free life formulated.
3. Family relationships/enabling issues being addressed.
4. Treatment program successfully begun.
5. Condition, prognosis, and therapeutic regimen understood.